SLG
GH icon

Stanley-Laman Group’s Guardant Health GH Stock Holding History

Stanley-Laman Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,448
Closed -$1.07M – 254
2022
Q2 		$1.07M Sell
26,448
-876
-3% -$43.4K 0.19% 156
2022
Q1 		$1.81M Buy
27,324
+9,467
+53% +$648K 0.25% 138
2021
Q4 		$1.79M Buy
17,857
+12,507
+234% +$1.29M 0.21% 149
2021
Q3 		$669K Buy
+5,350
New +$636K 0.09% 207

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Stanley-Laman Group's GH Position: Q3 2022 in Review

Stanley-Laman Group sold out of Guardant Health (GH) in Q3 2022, closing a stake of 26,448 shares — an estimated $1.07M sold.

Stanley-Laman Group first reported a position in GH in Q3 2021 and held it in 4 quarters. The position peaked at $1.81M in Q1 2022. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

  • Stanley-Laman Group reported no remaining Guardant Health position as of Q3 2022 after selling out during the quarter.
  • Stanley-Laman Group sold 26,448 Guardant Health shares in Q3 2022, an estimated $1.07M.
  • Stanley-Laman Group first reported a position in Guardant Health in Q3 2021 and held it in 4 quarters.
  • Stanley-Laman Group's Guardant Health position peaked at $1.81M in Q1 2022.
  • 328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Stanley-Laman Group's 13F filing for Q3 2022, filed 18 Oct 2022.